[{"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - OtherThe intervention group includes patients with moderate to severe COVID-19 symptoms who have been diagnosed with coronavirus by PCR: (1) CoviGlobulin (rabbit polyclonal antibody) intake of 1-3 mg per kg body weight Body (1-3 mg / kg / d) for 2-4 days. (2) Receive the basic COVID-19 treatment based on the protocol approved by the Ministry of Health", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - OtherControl group: Receive basic COVID-19 treatment based on protocol approved by the Ministry of Health", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 347, "treatment_name": "Coviglobulin (rabbit polyclonal antibody)", "treatment_type": "Advanced therapy medicinal products (atmp)", "pharmacological_treatment": "Biological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]